HOTLINE

+86-571-56103619

HOME
COMPANY
Products
News
Information
Contact Us

Hangzhou Xingwan Pharmaceutical Co., LtdHome
Products

Products

Small Volume Injection
Powder for Injection
Theraputic Infusion
Fluid Balance Infusion
Capsules
Tablets

Exhibitions

Welcome to Visit Us at CPHI China 2023
Welcome to Visit Us at API China 2023(Spring)
Welcome to Visit Us at API China 2021
Welcome to Visit Us at CPHI China 2020
Welcome to Visit Us at CPHI India 2019

Pharma News

Retagliptin Phosphate Tablets approved by China NMPA for type 2 diabetes
Centralized medical procurement saves patients more money
Biosimilar Tocilizumab Injection approved for marketing
How to choose children’s cosmetics scientifically
FDA grants EUA to Lilly’s bebtelovimab for Covid-19 treatment
4 Chinese COVID-19 vaccines undergoing phase-3 clinical trials
China Develops novel rabies vaccine

About Us
Global Market
Contact Us
Join Us

Copyright 2023 Hangzhou Xingwan Pharmaceutical Co., Ltd. All rights reserved.